BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
131 hedge funds and large institutions have $1.42B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
25% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 36
10% more funds holding
Funds holding: 119 → 131 (+12)
Holders
131
Holding in Top 10
11
Calls
$14.3M
Puts
$7.89M
Top Buyers
| 1 | +$85.2M | |
| 2 | +$30.1M | |
| 3 | +$25M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$18.5M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$16.8M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$11.5M | |
| 3 | -$10.3M | |
| 4 |
DM
Deerfield Management
New York
|
-$8.97M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$8.73M |